NNC0090-2746

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NNC0090-2746, covering 2020-07-21 to 2020-07-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With Metformin [Phase 2]

See pricing